No Data
No Data
Protara Therapeutics' TARA-002 Shows Promising Potential in NMIBC Treatment, Justifying Buy Rating
Protara Therapeutics To Present THRIVE-1 Study Results On Choline Deficiency At ASPEN 2025
Express News | Protara Therapeutics To Present At American Society for Parenteral and Enteral Nutrition 2025 Nutrition Science & Practice Conference MAr. 22-25
Protara Therapeutics Announces Presentation of Results From THRIVE-1 Study
Express News | Protara Therapeutics: Dosing of First Patient in Thrive-3 Registrational Trial Expected in 1H 2025
Express News | Protara Therapeutics Announces Encore Presentation of Results From Thrive-1 Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support